Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

InMed Pharmaceuticals Inc INM

InMed Pharmaceuticals Inc. is a pharmaceutical company. It develops a pipeline of small molecule drug candidates targeting the CB1/CB2 receptors. Its InMed Pharmaceuticals segment is engaged in the research and development of small molecule pharmaceuticals drug candidates. Its BayMedica Commercial segment is engaged in the manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its pharmaceutical pipeline consists of three programs, with drug candidates targeting Alzheimer’s disease, dry age-related macular degeneration, and Epidermolysis Bullosa. Its INM-901 is a drug candidate being developed as a potential treatment for Alzheimer’s disease. Its INM-089 is cannabinoid analog being studied for its potential as a treatment for age-related macular degeneration. Its INM-755 is a cannabinol topical cream which has completed Phase 2 clinical trial studies for the treatment of epidermolysis bullosa.


NDAQ:INM - Post by User

Comment by Bullknit101on Feb 07, 2021 9:39am
137 Views
Post# 32495241

RE:RE:RE:RE:Absolute joke!!

RE:RE:RE:RE:Absolute joke!!You have to scroll through Todd Harrison Twitter feeds after the Jazz GW Pharma news. He included tickers $INM as well as other like Cardiol Thera, Tetra Bio etc... So leaves me to believe he still has a position. Btw I didnt like the Friday night news release, Friday night's for hidding. On another note, some tech analysis I came across (some podcast stock talk on twitter) showed that if we break $5.23 CAD, then it's going back down, but if it stays above it may go to $10. I'm still holding but buying other good us msos which are doing well. Legislation is coming out soon and Safe Banking is going to drive SPs higher.
<< Previous
Bullboard Posts
Next >>